Received Nov 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
sleeping issues; dilation in her eyes; This is a spontaneous report received from an Other HCP. Other Case identifier(s): 10000433404 (Genentech). A 74-year-old female patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SLEEP DISORDER (non-serious), outcome "unknown", described as "sleeping issues"; MYDRIASIS (non-serious), outcome "unknown", described as "dilation in her eyes". Additional information: The patient's past medical history, concurrent condition and concomitant medication were not reported. On unknown date, patient started therapy with Pfizer covid vaccine for unknown indication. On unknown date, it was reported that patient a Pfizer Covid shot and had a bad reaction. Patient stated she has sleeping issues and dilation in her eyes. Batch/lot number is not provided, and it cannot be obtained.